Logo image of IBG

INNOVATION BEVERAGE GROUP LT (IBG) Stock Fundamental Analysis

NASDAQ:IBG - Nasdaq - AU0000226177 - Common Stock - Currency: USD

0.68  -0.03 (-4.23%)

Fundamental Rating

2

Taking everything into account, IBG scores 2 out of 10 in our fundamental rating. IBG was compared to 32 industry peers in the Beverages industry. IBG has a bad profitability rating. Also its financial health evaluation is rather negative. IBG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IBG had negative earnings in the past year.
IBG had a positive operating cash flow in the past year.
IBG Yearly Net Income VS EBIT VS OCF VS FCFIBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

IBG has a Return On Assets of -45.43%. This is amonst the worse of the industry: IBG underperforms 87.50% of its industry peers.
The Return On Equity of IBG (-915.45%) is worse than 87.50% of its industry peers.
Industry RankSector Rank
ROA -45.43%
ROE -915.45%
ROIC N/A
ROA(3y)-43.53%
ROA(5y)N/A
ROE(3y)-558.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBG Yearly ROA, ROE, ROICIBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

IBG has a Gross Margin of 65.26%. This is amongst the best in the industry. IBG outperforms 100.00% of its industry peers.
IBG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBG Yearly Profit, Operating, Gross MarginsIBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

IBG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IBG has about the same amount of shares outstanding.
The debt/assets ratio for IBG has been reduced compared to a year ago.
IBG Yearly Shares OutstandingIBG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
IBG Yearly Total Debt VS Total AssetsIBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

IBG has an Altman-Z score of -1.78. This is a bad value and indicates that IBG is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.78, IBG is doing worse than 75.00% of the companies in the same industry.
IBG has a debt to FCF ratio of 51.41. This is a negative value and a sign of low solvency as IBG would need 51.41 years to pay back of all of its debts.
With a Debt to FCF ratio value of 51.41, IBG is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
IBG has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of IBG (1.60) is worse than 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 51.41
Altman-Z -1.78
ROIC/WACCN/A
WACC8.41%
IBG Yearly LT Debt VS Equity VS FCFIBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M

2.3 Liquidity

A Current Ratio of 0.81 indicates that IBG may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.81, IBG is doing worse than 81.25% of the companies in the same industry.
IBG has a Quick Ratio of 0.81. This is a bad value and indicates that IBG is not financially healthy enough and could expect problems in meeting its short term obligations.
IBG has a Quick ratio of 0.50. This is in the lower half of the industry: IBG underperforms 78.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.5
IBG Yearly Current Assets VS Current LiabilitesIBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

4

3. Growth

3.1 Past

IBG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.23%, which is quite impressive.
IBG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.52%.
EPS 1Y (TTM)51.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.23%
Revenue 1Y (TTM)-30.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-30.52%

3.2 Future

Based on estimates for the next years, IBG will show a very strong growth in Earnings Per Share. The EPS will grow by 20.48% on average per year.
The Revenue is expected to grow by 24.40% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2Y9.34%
EPS Next 3Y20.48%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y20.16%
Revenue Next 3Y24.4%
Revenue Next 5YN/A

3.3 Evolution

IBG Yearly Revenue VS EstimatesIBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2025 2026 2M 4M 6M
IBG Yearly EPS VS EstimatesIBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.05 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IBG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IBG Price Earnings VS Forward Price EarningsIBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

IBG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 198.29
EV/EBITDA N/A
IBG Per share dataIBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as IBG's earnings are expected to grow with 20.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.34%
EPS Next 3Y20.48%

More info and screens

0

5. Dividend

5.1 Amount

IBG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATION BEVERAGE GROUP LT

NASDAQ:IBG (5/21/2025, 10:51:06 AM)

0.68

-0.03 (-4.23%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.9%
Inst Owner ChangeN/A
Ins Owners23.39%
Ins Owner ChangeN/A
Market Cap5.67M
Analysts80
Price Target4.08 (500%)
Short Float %0.63%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.8
P/FCF 198.29
P/OCF 188.41
P/B 25.78
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.5%
OCF(TTM)0
OCFY0.53%
SpS0.38
BVpS0.03
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.43%
ROE -915.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.26%
FCFM 0.91%
ROA(3y)-43.53%
ROA(5y)N/A
ROE(3y)-558.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 51.41
Debt/EBITDA N/A
Cap/Depr 0.63%
Cap/Sales 0.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.5
Altman-Z -1.78
F-Score5
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)114.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.23%
EPS Next YN/A
EPS Next 2Y9.34%
EPS Next 3Y20.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-30.52%
Revenue Next YearN/A
Revenue Next 2Y20.16%
Revenue Next 3Y24.4%
Revenue Next 5YN/A
EBIT growth 1Y35.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y25.29%
EBIT Next 5YN/A
FCF growth 1Y100.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.05%
OCF growth 3YN/A
OCF growth 5YN/A